Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Pathways
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: What's New
What's New

Jobs - Posted 2 September 2010
Director of the Division of Neuroscience, National Institute on Aging: Department of Health and Human Services, National Institutes of Health, Bethesda, Maryland.

Comments - Posted 1 September 2010
Read remarks by Terrence Town about Boyd TD et al.
PAPER: GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice.

Comments - Posted 1 September 2010
Read remarks by Niklas Mattsson about Siderowf A et al.
PAPER: CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

Comments - Posted 1 September 2010
Read remarks by Elliott Mufson
NEWS: Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial

Comments - Posted 1 September 2010
Read remarks by Torleif Härd about Zhuang W et al.
PAPER: Discriminating early stage A{beta}42 monomer structures using chirality-induced 2DIR spectroscopy in a simulation study.

Comments - Posted 1 September 2010
Read remarks by Giampaolo Merlini, Laura Obici about Bugiani O et al.
PAPER: Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP.

Comments - Posted 1 September 2010
Read remarks by Hugo Geerts
NEWS: Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor

Comments - Posted 1 September 2010
Read remarks by Jochen Herms
NEWS: Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor

Research Models: TDP-43 - Posted 1 September 2010
We've added the Tardbp+/- mouse model to our TDP-43 Research Models page.

Comments - Posted 31 August 2010
Read remarks by Thomas Bayer, Vivek Venkataramani about Paris D et al.
PAPER: Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.

In Search of Research Participants - Posted 31 August 2010
California Clinical Trials is conducting a short inpatient medical research study.

Jobs - Posted 31 August 2010
Assistant Professor or Associate Professor: West Virginia University Department of Psychology, Morgantown, West Virginia.

Comments - Posted 31 August 2010
Read remarks by David Teplow about Sandberg A et al.
PAPER: Stabilization of neurotoxic Alzheimer amyloid-{beta} oligomers by protein engineering.

Comments - Posted 27 August 2010
Read remarks by Cathy Roe about Paris D et al.
PAPER: Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.

Comments - Posted 27 August 2010
Read remarks by William Klunk about Kadir A et al.
PAPER: Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

Jobs - Posted 26 August 2010
Senior Research Associate-Neuroscience: Genentech, South San Francisco, California.

Jobs - Posted 26 August 2010
Research Associate-Neuroscience: Genentech, South San Francisco, California.

Jobs - Posted 26 August 2010
Scientist-Neuroscience: Genentech, South San Francisco, California.

Conferences - Posted 26 August 2010
Immunological Mechanisms of Vaccination: 27 October 2010 - 1 November 2010, Sheraton Seattle Hotel, Seattle, WA, U.S.A.

Jobs - Posted 26 August 2010
Scientist/Senior Scientist, Neurology Pharmacodynamic Biomarkers: Genentech, South San Francisco, California.

AD Experiences - Posted 26 August 2010
The latest issue (Vol. 15, No. 3) of Perspectives, a quarterly newsletter written for people with dementia, is available on our AD Experiences page.

Polls
 
Should the FDA be allowed to use data from overseas clinical trials?

Absolutely, we are running out of viable subjects in the U.S.
 9
 
Yes, so long as the data is reliable
 31
 
No, the trials are not as rigorous
 3
 
No, the data should be repeated in the U.S.
 5
 
No, the drug sponsors are just trying to cut corners
 3
 
Responses: 51
 
 
 
 
 
Archived Polls
 
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2010 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad